Early-life cisplatin exposure induces neuroinflammation and chemotherapy-induced neuropathic pain
Disease Models & Mechanisms · 2024
DOI: 10.1242/dmm.052062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2024. Verfasst von Marlene Da Vitoria Lobo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK. Hauptthemen laut MEDLINE: Cisplatin, Neuralgia, Ganglia, Spinal, Neuroinflammatory Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Foundation for the Study of Diabetes, Rosetrees Trust, Nottingham Trent University.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Chemotherapy-induced neuropathic pain (CINP) is a common adverse health-related comorbidity that manifests later in life in patients with paediatric cancer. Current analgesia is ineffective, aligning closely with our lack of understanding of CINP. The aim of this study was to investigate how cisplatin induces nerve growth factor (NGF)-mediated neuroinflammation and nociceptor sensitisation. In a rat model of cisplatin-induced survivorship pain, cisplatin induced a neuroinflammatory environment in the dorsal root ganglia (DRG), demonstrated by NGF-positive macrophages infiltrating into the DRG. Cisplatin-treated CD11b- and F4/80-positive macrophages expressed more NGF compared to those treated with vehicle control. Mouse primary DRG sensory neuronal cultures demonstrated enhanced NGF-dependent TRPV1-mediated nociceptor activity after cisplatin treatment. Increased nociceptor activity was also observed when cultured mouse DRG neurons were treated with conditioned medium from cisplatin-activated macrophages. Elevated nociceptor activity was inhibited in a dose-dependent manner by an NGF-neutralising antibody. Intraperitoneal administration of the NGF-neutralising antibody reduced cisplatin-induced mechanical hypersensitivity and aberrant nociceptor intraepidermal nerve fibre density. These findings identify that a monocyte- or macrophage-driven NGF–TrkA pathway is a novel analgesic target for adult survivors of childhood cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.
- Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK.
ORCID-Profile: Richard Philip Hulse
Förderung
- European Foundation for the Study of Diabetes
- Rosetrees Trust
- Nottingham Trent University
- Boehringer Ingelheim
Zitieren
APA
Da Vitoria Lobo, M., Hardowar, L., Valentine, T., Tomblin, L., Guest, C., Sharma, D., Dickins, B., Paul-Clark, M., & Hulse, R. P. (2024). Early-life cisplatin exposure induces neuroinflammation and chemotherapy-induced neuropathic pain. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052062
Vancouver
Da Vitoria Lobo M, Hardowar L, Valentine T, Tomblin L, Guest C, Sharma D, et al. Early-life cisplatin exposure induces neuroinflammation and chemotherapy-induced neuropathic pain. Disease Models & Mechanisms. 2024. doi:10.1242/dmm.052062
BibTeX
@article{DaVitoriaLobo2024,
author = {Da Vitoria Lobo, Marlene and Hardowar, Lydia and Valentine, Tameille and Tomblin, Lucy and Guest, Charlotte and Sharma, Dhyana and Dickins, Benjamin and Paul-Clark, Mark and Hulse, Richard Philip},
title = {Early-life cisplatin exposure induces neuroinflammation and chemotherapy-induced neuropathic pain},
journal = {Disease Models & Mechanisms},
year = {2024},
doi = {10.1242/dmm.052062}
}
EUVIMED